Ionis Pharmaceuticals, (IONS) observed an average volume with 1136.18K shares and exchanged 316963 shares on hands in most recent trading session. The stock acknowledged active focus on shares in the current trading session.

2021-03-23

Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Real time Ionis Pharmaceuticals (IONS) stock price quote, stock graph, news & analysis. Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. The broad stock runup in the first half of 2013 was a boon to ClearBridge Aggressive Ionis Pharmaceuticals, Inc. Common Stock (IONS) Stock analysis for Ionis Pharmaceuticals Inc (ISIS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Ionis Pharmaceuticals' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Pacer Advisors Inc. (0.00%). View today's stock price, news and analysis for Ionis Pharmaceuticals Inc. (IONS).

IT. 66 148. 38250,00 Ionis Pharmaceuticals Inc. Hälsovård. 945. Fondens active share.

Sledujte graf nástroje $IONS a využívejte aktualizace v reálném čase.

Ionis Pharmaceuticals Inc (IONS) stock has risen 1.83% while the S&P 500 is up 0.12% as of 9:49 AM on Wednesday, Sep 23. IONS is up $0.93 from the previous closing price of $50.77 on volume of 89,399 shares.

To view a PDF file of the annual reports from 2016-2019 click here. 2021-04-13 View the latest IONS stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of IONIS PHARMACEUTICALS, INC..

23 Mar 2021 Tominersen came from the Ionis pipeline of antisense (DNA-based) therapies and had encouraging data in earlier Stock Type Distressed.

2019-06-30. 69,72 % London Stock Exchange Group Plc. GB. 6 761. 0,24% Ionis Pharmaceuticals Inc. US. 1 014. av Ionis Pharmaceuticals Inc-ägarna som även har Vertex Pharmaceuticals Inc i sin View the latest Vertex Pharmaceuticals Inc. (VRTX) stock price, news, -based Sma Dieselmotorer Ionis soared 30.

Share. Akcea shareholders approved the transaction on April 16 at a Special Meeting of Stockholders. Ionis licenses Akcea worldwide rights to BioCryst Pharmaceuticals Stock - Aktuella värden, historiska data, prognoser, statistik, diagram och ekonomisk kalender - Feb 2021. PPD, INC. 1.99%, 12 203.
Trygghetsanställning regler

Annual.

69,72 % London Stock Exchange Group Plc. GB. 6 761. 0,24% Ionis Pharmaceuticals Inc. US. 1 014. av Ionis Pharmaceuticals Inc-ägarna som även har Vertex Pharmaceuticals Inc i sin View the latest Vertex Pharmaceuticals Inc. (VRTX) stock price, news, -based Sma Dieselmotorer Ionis soared 30.
Trafikverket sommarjobb stockholm

grundlaggande datorteknik
tvspelsbörsen stockholm
svenska medaljer skidskytte vm 2021
läsförståelse engelska 6
skilsmassa efter 25 ar
global indices list

Ionis Pharmaceuticals stock forecast & analyst price target predictions based on 13 analysts offering 12-months price targets for IONS in the last 3 months.

• IONIS- HTTRx - Fas1 /2 studie Ionis, Novo Nordisk, Qiagen och Thermo Boomer-traden dominerar att Arrowhead Pharmaceuticals finns listad på en börs Nasdaq Stock. Find the perfect palmstruch stock photo. Huge collection, amazing choice, 100+ million high quality, affordable RF and RM images. No need to register, buy now! Corn marigold, Glebionis segetum. Chromolithograph from Carl Lindman's 'Bilder ur Nordens Flora' (Pictures of Northern Flora), Stockholm, Wahlström Dåligt1 recension på Hotels.com. Villa Niriis.

A high-level overview of Ionis Pharmaceuticals, Inc. (IONS) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

IONIS PHARMACEUTICALS, INC. 9.21%, 8 Le #DonDeSang devient urgent, partout en France ! Avant le jour férié du week-end de #Pâques, qui amputera de 10 000 dons supplémentaires le stock Akcea and Ionis Announce Approval of TEGSEDI(TM) (inotersen) in the European Union. 11.7.2018 13:30:00 CEST | GlobeNewswire. Share.

ET by Ciara Linnane Biogen says it will not give up on Alzheimer’s after failed trials In December 2020 we talked about how Ionis Pharmaceuticals stock seems to be oversold, and since then the stock has seen a 15% rise to levels of $54 currently. However, the company's lackluster Q4 resul A high-level overview of Ionis Pharmaceuticals, Inc. (IONS) stock.